AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

P3 Health Partners Inc.

$8.43 +$4.93 (+140.86%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$8.36
Day Range
$8.35$8.5
Year Range
$1.52$16.89
Market Cap
27.62M
AVG Volume
1.29M
Trailing/Forward PE
-0.26/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD)
0500M1B1.5B2B202020212022202320242025
PIII Revenue (USD) by year
PeriodRevenue (USD)
20251.46B
20241.5B
20231.27B
20221.05B
2021637.36M
2020491.06M
Net Income (USD)
-300M-200M-100M0202020212022202320242025
PIII Net Income (USD) by year
PeriodNet Income (USD)
2025-147.95M
2024-135.85M
2023-57.77M
2022-270.13M
2021-156.48M
2020-31.41M
Operating Income (USD)
-2B-1.5B-1B-500M0202020212022202320242025
PIII Operating Income (USD) by year
PeriodOperating Income (USD)
2025-270.3M
2024-320.66M
2023-167.93M
2022-1.56B
2021-187.95M
2020-28.59M
EBITDA (USD)
-1.5B-1B-500M0202020212022202320242025
PIII EBITDA (USD) by year
PeriodEBITDA (USD)
2025-181.86M
2024-197.76M
2023-81.07M
2022-1.46B
2021-191.29M
2020-27.79M
Cash Flows (USD)
-150M-100M-50M0202020212022202320242025
PIII Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-91.12M
2024-110.13M
2023-77.86M
2022-128.05M
2021-111.26M
2020-36.4M
EPS (USD)
-400-300-200-1000202020212022202320242025
PIII EPS (USD) by year
PeriodEPS (USD)
2025-45.2
2024-51.81
2023-28.15
2022-325.78
2021-181.28
2020-29.62
Expenses (USD)
050M100M150M200MSG&ACapex202020212022202320242025
PIII Expenses (USD) by year
PeriodExpenses (USD)
2025107.23M
2024113.93M
2023127.42M
2022164.61M
2021125.81M
202060.05M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt202020212022202320242025
PIII Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202525.01M
202438.82M
202336.32M
202218.46M
2021140.48M
202036.26M
Debt ratios
-0.15-0.1-0.05-0202320242025
PIII Debt ratios by year
PeriodDebt ratios
2025-0.14
2024-0.07
2023-0.05
Margins
0%20%40%60%80%202020212022202320242025
PIII Margins by year
PeriodMargins
202548.68%
202448.76%
202369.26%
202275.72%
202168.46%
20201.34%
Return on Capital
-100%-50%0%50%100%150%202020212022202320242025
PIII Return on Capital by year
PeriodReturn on Capital
2025105.5%
2024-90.85%
2023-13.32%
2022-51.68%
2021-7.58%
202024.12%
Shares Outstanding
01M2M3M4M202020212022202320242025
PIII Shares Outstanding by year
PeriodShares Outstanding
20253.28M
20243.25M
20232.31M
2022831.58K
2021831.58K
2020790.62K
Book Value Per Share (USD)
-10000100020003000202020212022202320242025
PIII Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-42.74
202445.97
2023188.06
2022628.52
20212482.23
2020-164.7
Total Assets (USD)
01B2B3B202020212022202320242025
PIII Total Assets (USD) by year
PeriodTotal Assets (USD)
2025656.64M
2024783.42M
2023860.97M
2022876.74M
20212.36B
2020106.44M
Employee Count
02004006002021202220242025
PIII Employee Count by year
PeriodEmployee Count
2025320
2024360
2022600
2021500
Free Cash Flow Yield
-2000%-1500%-1000%-500%0%med -451.77%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PIII Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-460.1%
Sep 26-414.83%
Aug 26-420.68%
Aug 26-376.2%
Aug 26-362.83%
Aug 26-223.56%
Jul 26-263.36%
Jul 26-269.11%
Jul 26-239.26%
Jul 26-264.16%
Jul 26-227.69%
Jun 26-228.9%
Jun 26-240.82%
Jun 26-211.68%
Jun 26-223.56%
May 26-212.55%
May 26-196.12%
May 26-229.3%
May 26-782.3%
May 26-947.84%
Apr 26-1051.96%
Apr 26-1068.14%
Apr 26-1093.37%
Apr 26-1080.61%
Mar 26-944.62%
Mar 26-1295.2%
Mar 26-1188.64%
Mar 26-1684.35%
Feb 26-1771.74%
Feb 26-1755.18%
Feb 26-1755.18%
Feb 26-1747.02%
Jan 26-1956.3%
Jan 26-1478.78%
Jan 26-1173.78%
Jan 26-1155.72%
Jan 26-1073.17%
Dec 25-1052.13%
Dec 25-911.67%
Dec 25-723.72%
Dec 25-716.81%
Nov 25-695.57%
Nov 25-657.81%
Nov 25-549.14%
Nov 25-502.88%
Oct 25-454.61%
Oct 25-449.98%
Oct 25-459.86%
Oct 25-432.37%
Oct 25-459.86%
Sep 25-407.56%
Sep 25-482.74%
Sep 25-462.54%
Sep 25-453.57%
Aug 25-477.53%
Aug 25-553.24%
Aug 25-586.7%
Aug 25-565.72%
Aug 25-515.69%
Jul 25-521.36%
Jul 25-573.42%
Jul 25-608.4%
Jul 25-594.09%
Jun 25-595.02%
Jun 25-606.45%
Jun 25-567.41%
Jun 25-572.55%
May 25-512.9%
May 25-519.22%
May 25-474.38%
May 25-388.72%
May 25-384.75%
Apr 25-378.72%
Apr 25-366.42%
Apr 25-445.49%
Apr 25-396%
Mar 25-391.42%
Mar 25-246.19%
Mar 25-241.97%
Mar 25-228.89%
Feb 25-224.05%
Feb 25-203.58%
Feb 25-184.11%
Feb 25-216.04%
Jan 25-235.25%
Jan 25-213.86%
Jan 25-205.56%
Jan 25-196.95%
Jan 25-170.74%
Dec 24-211.72%
Dec 24-214.95%
Dec 24-206.56%
Dec 24-183.31%
Nov 24-169.38%
Nov 24-198.8%
Nov 24-184.91%
Nov 24-105.24%
Nov 24-107.24%
Oct 24-97.21%
Oct 24-86.93%
Price to Sales
00.010.020.030.040.05med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PIII Price to Sales by year
PeriodPrice to Sales
Sep 260.02
Sep 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Aug 260.03
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.03
Jun 260.03
Jun 260.02
Jun 260.03
Jun 260.03
May 260.03
May 260.03
May 260.03
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Dec 250.01
Dec 250.01
Dec 250.01
Dec 250.01
Nov 250.01
Nov 250.01
Nov 250.02
Nov 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.01
Aug 250.02
Jul 250.02
Jul 250.01
Jul 250.01
Jul 250.01
Jun 250.01
Jun 250.01
Jun 250.01
Jun 250.01
May 250.02
May 250.02
May 250.02
May 250.02
May 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Feb 250.02
Feb 250.02
Feb 250.03
Feb 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.03
Dec 240.02
Dec 240.02
Dec 240.02
Dec 240.03
Nov 240.03
Nov 240.02
Nov 240.03
Nov 240.04
Nov 240.04
Oct 240.04
Oct 240.04
Price to Book
00.511.5med 0.19Aug 24Nov 24Feb 25Jun 25Sep 25Jan 26Sep 26
PIII Price to Book by year
PeriodPrice to Book
Sep 260.39
Sep 260.43
Aug 260.42
Aug 260.47
Aug 260.49
Mar 260.5
Mar 260.55
Mar 260.39
Feb 260.37
Feb 260.37
Feb 260.37
Feb 260.37
Jan 260.33
Jan 260.44
Jan 260.55
Jan 260.56
Jan 260.6
Dec 250.62
Dec 250.71
Dec 250.9
Dec 250.9
Nov 250.93
Nov 250.99
Nov 251.18
Nov 250.3
Oct 250.33
Oct 250.33
Oct 250.32
Oct 250.34
Oct 250.32
Sep 250.37
Sep 250.31
Sep 250.32
Sep 250.33
Aug 250.31
Aug 250.27
Aug 250.25
Aug 250.18
Aug 250.2
Jul 250.2
Jul 250.18
Jul 250.17
Jul 250.17
Jun 250.17
Jun 250.17
Jun 250.18
Jun 250.18
May 250.2
May 250.2
May 250.22
May 250.19
May 250.19
Apr 250.19
Apr 250.2
Apr 250.17
Apr 250.19
Mar 250.19
Mar 250.11
Mar 250.11
Mar 250.11
Feb 250.12
Feb 250.13
Feb 250.14
Feb 250.12
Jan 250.11
Jan 250.12
Jan 250.13
Jan 250.13
Jan 250.15
Dec 240.12
Dec 240.12
Dec 240.13
Dec 240.14
Nov 240.15
Nov 240.13
Nov 240.14
Nov 240.14
Nov 240.14
Oct 240.15
Oct 240.17
Oct 240.12
Oct 240.14
Sep 240.15
Sep 240.16
Sep 240.18
Sep 240.17
Aug 240.19
Aug 240.19
Aug 240.22
Aug 240.23
Aug 240.18
Jul 240.19
Jul 240.17
Jul 240.16
Jul 240.15
Jun 240.14
Jun 240.17
Jun 240.19
Jun 240.17
May 240.15
P3 Health Partners Inc.
PIII
Stockpicker

Video analysis: PIII

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PIII

Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)

defenseworld.net · 9 Sep 2026

Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ: PIII - Get Free Report) and Molina Healthcare (NYSE: MOH - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Volatility and Risk P3 Health Partners has

P3 Health Partners Q2 Earnings Call Highlights

marketbeat.com · 10 Aug 2026

P3 Health Partners Q2 Earnings Call Highlights

P3 Health Partners NASDAQ: PIII reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

seekingalpha.com · 10 Aug 2026

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Announces Second Quarter 2026 Results

businesswire.com · 10 Aug 2026

P3 Health Partners Announces Second Quarter 2026 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2026. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements.

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

businesswire.com · 21 Jul 2026

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2026 on Monday, August 10, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter 2026 Earnings C.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.